Abstract
Bisbenzimidazoles, have shown various biological activities viz. antineoplastic, anti-tumor, anti-fungal, anti-inflammatory, hypoglycemia treatment and physiological disorders, besides other pharmacological effects. Structural modifications of the benzimidazole nucleus are being carried out in several ways in order to anticipate enhanced biological activities. The synthesis of bis-benzimidazoles is one such attempt, where the two benzimidazole nuclei are united together using a variety of linkers and points of linkages. These structural permutations and combinations have given a large number of available bisbenzimidazole compounds for pharmacological and biological research. A number of reviews have been published over the past decade on the compilation of the biological activities of bisbenzimidazoles. However, we could not locate any report covering the general strategies followed for the synthesis of these compounds. The present review provides an in depth view of synthetic routes for preparation of symmetric bisbenzimidazoles.
Keywords: Bisbenzimidazole, o-phenylenediamine, linkers, one pot synthesis.
Mini-Reviews in Organic Chemistry
Title:Synthetic Routes to Symmetric Bisbenzimidazoles: A Review
Volume: 9 Issue: 4
Author(s): Leena Khanna, Siva S. Panda and Pankaj Khanna
Affiliation:
Keywords: Bisbenzimidazole, o-phenylenediamine, linkers, one pot synthesis.
Abstract: Bisbenzimidazoles, have shown various biological activities viz. antineoplastic, anti-tumor, anti-fungal, anti-inflammatory, hypoglycemia treatment and physiological disorders, besides other pharmacological effects. Structural modifications of the benzimidazole nucleus are being carried out in several ways in order to anticipate enhanced biological activities. The synthesis of bis-benzimidazoles is one such attempt, where the two benzimidazole nuclei are united together using a variety of linkers and points of linkages. These structural permutations and combinations have given a large number of available bisbenzimidazole compounds for pharmacological and biological research. A number of reviews have been published over the past decade on the compilation of the biological activities of bisbenzimidazoles. However, we could not locate any report covering the general strategies followed for the synthesis of these compounds. The present review provides an in depth view of synthetic routes for preparation of symmetric bisbenzimidazoles.
Export Options
About this article
Cite this article as:
Khanna Leena, Panda S. Siva and Khanna Pankaj, Synthetic Routes to Symmetric Bisbenzimidazoles: A Review, Mini-Reviews in Organic Chemistry 2012; 9 (4) . https://dx.doi.org/10.2174/157019312804699474
DOI https://dx.doi.org/10.2174/157019312804699474 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
Call for Papers in Thematic Issues
Navigating the 2D Universe in Organic Chemistry
This special issue explores the transformative impact of two-dimensional (2D) materials on the realm of organic chemistry, unraveling new possibilities for synthesis, functionalization, and applications of organic compounds. Focused on the unique chemistry within this novel dimension, the issue highlights breakthroughs in the field of 2D organic chemistry. Contributions are ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Small Molecules and Future Regenerative Medicine
Current Topics in Medicinal Chemistry Targeting Heat Shock Proteins 70/90 and Proteasome for Cancer Therapy
Current Medicinal Chemistry Synergistic Interactions between GW8510 and Gemcitabine in an In Vitro Model of Pancreatic Cancer
Anti-Cancer Agents in Medicinal Chemistry Current Status of Thalidomide and CC-5013 in the Treatment of Metastatic Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Polyphenols: A Nutraceutical Approach Against Diseases
Recent Patents on Food, Nutrition & Agriculture Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to Reevaluate their Toxicity
Current Medicinal Chemistry Are we Genomic Mosaics? Variations of the Genome of Somatic Cells can Contribute to Diversify our Phenotypes
Current Genomics Molecular Pathways of Endothelial Cell Activation for (Targeted) Pharmacological Intervention of Chronic Inflammatory Diseases
Current Vascular Pharmacology Development of Novel Therapeutic Drugs in Humans from Plant Antimicrobial Peptides
Current Protein & Peptide Science Unexpected High Levels of Vorinostat when Combined with Vinorelbine in Patients with Advanced Cancer
Current Clinical Pharmacology Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models
Current Medicinal Chemistry Building A New Treatment For Heart Failure-Transplantation of Induced Pluripotent Stem Cell-derived Cells into the Heart
Current Gene Therapy Reactive Oxygen and Nitrogen Species in Carcinogenesis: Implications of Oxidative Stress on the Progression and Development of Several Cancer Types
Mini-Reviews in Medicinal Chemistry Recent Development of Low-dose X-ray Cone-beam Computed Tomography
Current Medical Imaging Does Cyclic Dependent Kinase 5 Play a Significant Role in Determination of Stroke Outcome? Possible Therapeutic Implications
Central Nervous System Agents in Medicinal Chemistry Targeting Cancer Cells with Photoactive Silica Nanoparticles
Current Pharmaceutical Design miR-25 Mediates Retinal Degeneration Via Inhibiting ITGAV and PEDF in Rat
Current Molecular Medicine A Pan-Cancer Review of <i>ALK</i> Mutations: Implications for Carcinogenesis and Therapy
Current Cancer Drug Targets PASylation as a Powerful Technology for Improving the Pharmacokinetic Properties of Biopharmaceuticals
Current Drug Delivery Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases
Current Pharmaceutical Biotechnology